ACCESSING CLASSIFIED FILES
Decrypting documents...
Your connection is being monitored
Back to Individuals
medium risk$40 million
Albert Bourla
Pfizer CEO
Pfizer CEO, Drug Pricing, Settlements
Overview
Albert Bourla leads Pfizer, which has paid billions in settlements for illegal marketing, bribing doctors, and other violations. While Pfizer produced the COVID-19 vaccine, the company has been criticized for pricing, patent protection that limited global access, and ongoing issues with drug pricing.
Key Affiliations
Controversies & Concerns
$2.3 BILLION: Largest healthcare fraud settlement (2009)
OFF-LABEL MARKETING: Illegally promoted drugs
BRIBERY: Paid doctors kickbacks
COVID PRICING: Criticized for vaccine prices
PATENT PROTECTION: Blocked generic access globally
DRUG PRICES: Continued price increases
Related Investigations (2)
Criminal Charges & Violations
2 documented violations
False Claims ActHealthcare fraud(CORPORATE SETTLEMENT $2.3B)
Anti-Kickback StatuteBribing physicians(PAST SETTLEMENTS)
Known Associates & Connections
Stephane Bancel
Fellow COVID-19 vaccine maker CEO, Moderna
Andrew Witty
Fellow pharmaceutical CEO during COVID era
Sources & Documentation
4 documented sources from official records, investigations, and reports
Personal Information
- Born
- October 21, 1961
- Birthplace
- Thessaloniki, Greece
Education
- •Aristotle University (Veterinary)
- •Aristotle University (PhD)
Key Timeline
October 21, 1961
Born in Greece
1993
Joins Pfizer
2019
Becomes Pfizer CEO
2020
COVID vaccine development